Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.251.181.491.371.03

What is the latest Working Capital/Sales ratio of BLISS GVS PHARMA ?

The latest Working Capital/Sales ratio of BLISS GVS PHARMA is 1.25 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.25
Mar20241.18
Mar20231.49
Mar20221.37
Mar20211.03

How is Working Capital/Sales of BLISS GVS PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 1.25
5.93
Mar2024 1.18
-20.81
Mar2023 1.49
8.76
Mar2022 1.37
33.01
Mar2021 1.03 -

Other Financial Ratios of BLISS GVS PHARMA


Compare Working Capital/Sales ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,510.3 Cr -12.1% -11.8% -5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,220.0 Cr 1.2% 2.3% -1.1% Stock Analytics
DIVIS LABORATORIES ₹168,486.0 Cr 0.9% -2.5% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,963.0 Cr 0.5% -1.5% 12.3% Stock Analytics
CIPLA ₹121,751.0 Cr 1.1% -1.6% 4.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,866.0 Cr 2.7% 2.9% 3.3% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

-12.1%

-11.8%

-5%

SENSEX

0.1%

0.9%

4.5%


You may also like the below Video Courses